China strives at biodiversiy monitoring

Under the lead of the CAS Institute of Botany in Chengdu, a network of 10 specialized monitoring centers was installed. Starting from a variety of monitoring methods and standards, it is planned to eventually establish national standards for the assessment and control...

China has developed 3d generation insulin glargine

According to official statistics, China has 110 million diabetic patients, and direct medical expenses from diabetes are said to account for 13 % of the total medical expenses. 3d generation recombinant insulin glargine is the treatment of choice for diabetes-I...